ERBB2 and breast cancer: Over the course of one year, mammary tumors only arose in recipient mice receiving ErbB2;Fsp-cre;Ptenfl/fl donor epithelium, suggesting a permanent, pro-tumorigenic effect elicited by neighboring PTEN-null stroma prior to injection (Fig. 1b, c).